Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer

Pathology Research and Practice

Volumn 205, Issue 1, 2009, Pages 1-9

  Rasheed, S ^a   Harris, A L ^b   Tekkis, P P ^a,c   Turley, H ^b   Silver, A ^d   McDonald, P J ^a   Talbot, I C ^a   Glynne Jones, R ^e   Northover, J M A ^a   Guenther, T ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Carbonic anhydrase 9; Hypoxia; Microvessel density; Rectal cancer

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADULT; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOLOGY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECTUM CANCER; RECTUM CARCINOMA; RECURRENCE RISK; SURVIVAL TIME; TUMOR VASCULARIZATION;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RECURRENCE; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 57249103323     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.08.008     Document Type: Article

References (45)

1. Beasley N.J., Wykoff C.C., Watson P.H., Leek R., Turley H., Gatter K., Pastorek J., Cox G.J., Ratcliffe P., and Harris A.L. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 61 (2001) 5262-5267
2. Bossi P., Viale G., Lee A.K., Alfano R., Coggi G., and Bosari S. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 55 (1995) 5049-5053
3. Brewer C.A., Liao S.Y., Wilczynski S.P., Pastorekova S., Pastorek J., Zavada J., Kurosaki T., Manetta A., Berman M.L., DiSaia P.J., and Stanbridge E.J. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. Gynecol. Oncol. 63 (1996) 337-344
4. British Cancer Death Rates, Br. Med. J. 328(2004) 303.
5. Bui M.H., Seligson D., Han K.R., Pantuck A.J., Dorey F.J., Huang Y., Horvath S., Leibovich B.C., Chopra S., Liao S.Y., Stanbridge E., Lerman M.I., Palotie A., Figlin R.A., and Belldegrun A.S. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin. Cancer Res. 9 (2003) 802-811
6. Cancer Facts and Figures, American Cancer Society, 2006.
7. Carracedo A., Lorente M., Egia A., Blazquez C., Garcia S., Giroux V., Malicet C., Villuendas R., Gironella M., Gonzalez-Feria L., Piris M.A., Iovanna J.L., Guzman M., and Velasco G. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 9 (2006) 301-312
8. Chen Y.B., Wan D.S., Zhan Y.Q., Zhou Z.W., Li W., and Chen G. Correlation of tumor microvessel density to metastasis and recurrence of rectal cancer. Ai. Zheng 23 (2004) 1203-1206
9. Chia S.K., Wykoff C.C., Watson P.H., Han C., Leek R.D., Pastorek J., Gatter K.C., Ratcliffe P., and Harris A.L. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J. Clin. Oncol. 19 (2001) 3660-3668
10. Choi H.J., Hyun M.S., Jung G.J., Kim S.S., and Hong S.H. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 55 (1998) 575-581
11. Cleven A.H., van Engeland M., Wouters B.G., and de Bruine A.P. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas. Cell Oncol. 29 (2007) 229-240
12. Colorectal Cancer Factsheet, Cancer Research UK, 2005.
13. Couvelard A., O'Toole D., Turley H., Leek R., Sauvanet A., Degott C., Ruszniewski P., Belghiti J., Harris A.L., Gatter K., and Pezzella F. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br. J. Cancer 92 (2005) 94-101
14. Dahlberg M., Pahlman L., Bergstrom R., and Glimelius B. Improved survival in patients with rectal cancer: a population-based register study. Br. J. Surg. 85 (1998) 515-520
15. Engel C.J., Bennett S.T., Chambers A.F., Doig G.S., Kerkvliet N., and O'Malley F.P. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am. J. Surg. Pathol. 20 (1996) 1260-1265
16. Garaj V., Puccetti L., Fasolis G., Winum J.Y., Montero J.L., Scozzafava A., Vullo D., Innocenti A., and Supuran C.T. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Bioorg. Med. Chem. Lett. 15 (2005) 3102-3108
17. Giatromanolaki A., Koukourakis M.I., Sivridis E., Pastorek J., Wykoff C.C., Gatter K.C., and Harris A.L. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 61 (2001) 7992-7998
18. Gulubova M., and Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J. Gastroenterol. Hepatol. (2007)
19. Hynninen P., Vaskivuo L., Saarnio J., Haapasalo H., Kivela J., Pastorekova S., Pastorek J., Waheed A., Sly W.S., Puistola U., and Parkkila S. Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours. Histopathology 49 (2006) 594-602
20. Ivanov S., Liao S.Y., Ivanova A., Danilkovitch-Miagkova A., Tarasova N., Weirich G., Merrill M.J., Proescholdt M.A., Oldfield E.H., Lee J., Zavada J., Waheed A., Sly W., Lerman M.I., and Stanbridge E.J. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am. J. Pathol. 158 (2001) 905-919
21. Kivela A.J., Parkkila S., Saarnio J., Karttunen T.J., Kivela J., Parkkila A.K., Bartosova M., Mucha V., Novak M., Waheed A., Sly W.S., Rajaniemi H., Pastorekova S., and Pastorek J. Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa. World J. Gastroenterol. 11 (2005) 2616-2625
22. Koukourakis M.I., Giatromanolaki A., Sivridis E., Simopoulos K., Pastorek J., Wykoff C.C., Gatter K.C., and Harris A.L. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin. Cancer Res. 7 (2001) 3399-3403
23. Li C., Gardy R., Seon B.K., Duff S.E., Abdalla S., Renehan A., O'Dwyer S.T., Haboubi N., and Kumar S. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br. J. Cancer 88 (2003) 1424-1431
24. Liao S.Y., Aurelio O.N., Jan K., Zavada J., and Stanbridge E.J. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 57 (1997) 2827-2831
25. Lindmark G., Gerdin B., Pahlman L., Bergstrom R., and Glimelius B. Prognostic predictors in colorectal cancer. Dis. Colon Rectum 37 (1994) 1219-1227
26. Loncaster J.A., Harris A.L., Davidson S.E., Logue J.P., Hunter R.D., Wycoff C.C., Pastorek J., Ratcliffe P.J., Stratford I.J., and West C.M. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61 (2001) 6394-6399
27. Murakami Y., Kanda K., Tsuji M., Kanayama H., and Kagawa S. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma. BJU Int. 83 (1999) 743-747
28. Niemela A.M., Hynninen P., Mecklin J.P., Kuopio T., Kokko A., Aaltonen L., Parkkila A.K., Pastorekova S., Pastorek J., Waheed A., Sly W.S., Orntoft T.F., Kruhoffer M., Haapasalo H., Parkkila S., and Kivela A.J. Carbonic anhydrase IX Is highly expressed in hereditary nonpolyposis colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1760-1766
29. Pastorek J., Pastorekova S., Callebaut I., Mornon J.P., Zelnik V., Opavsky R., Zat'ovicova M., Liao S., Portetelle D., Stanbridge E.J., et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9 (1994) 2877-2888
30. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9 (2003) 677-684
31. Robertson N., Potter C., and Harris A.L. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res. 64 (2004) 6160-6165
32. Saarnio J., Parkkila S., Parkkila A.K., Haukipuro K., Pastorekova S., Pastorek J., Kairaluoma M.I., and Karttunen T.J. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am. J. Pathol. 153 (1998) 279-285
33. Saczewski F., Innocenti A., Brzozowski Z., Slawinski J., Pomarnacka E., Kornicka A., Scozzafava A., and Supuran C.T. Carbonic anhydrase inhibitors. Selective inhibition of human tumor-associated isozymes IX and XII and cytosolic isozymes I and II with some substituted-2-mercapto-benzenesulfonamides. J. Enzyme Inhib. Med. Chem. 21 (2006) 563-568
34. Sagar P., and Pemberton J. Surgical management of locally recurrent rectal cancer. Br. J. Surg. 83 (1996) 293-304
35. Swinson D.E., Jones J.L., Richardson D., Wykoff C., Turley H., Pastorek J., Taub N., Harris A.L., and O'Byrne K.J. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J. Clin. Oncol. 21 (2003) 473-482
36. Tanigawa N., Amaya H., Matsumura M., Lu C., Kitaoka A., Matsuyama K., and Muraoka R. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res. 57 (1997) 1043-1046
37. Teicher B.A., Liu S.D., Liu J.T., Holden S.A., and Herman T.S. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res. 13 (1993) 1549-1556
38. Tomisaki S., Ohno S., Ichiyoshi Y., Kuwano H., Maehara Y., and Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 77 (1996) 1722-1728
39. Uemura H., Nakagawa Y., Yoshida K., Saga S., Yoshikawa K., Hirao Y., and Oosterwijk E. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br. J. Cancer 81 (1999) 741-746
40. Vermeulen P.B., Van den Eynden G.G., Huget P., Goovaerts G., Weyler J., Lardon F., Van Marck E., Hubens G., and Dirix L.Y. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br. J. Cancer 79 (1999) 316-322
41. Vullo D., Franchi M., Gallori E., Pastorek J., Scozzafava A., Pastorekova S., and Supuran C.T. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 13 (2003) 1005-1009
42. Winum J.Y., Dogne J.M., Casini A., de Leval X., Montero J.L., Scozzafava A., Vullo D., Innocenti A., and Supuran C.T. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties. J. Med. Chem. 48 (2005) 2121-2125
43. Wykoff C.C., Beasley N.J., Watson P.H., Turner K.J., Pastorek J., Sibtain A., Wilson G.D., Turley H., Talks K.L., Maxwell P.H., Pugh C.W., Ratcliffe P.J., and Harris A.L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60 (2000) 7075-7083
44. Wykoff C.C., Beasley N., Watson P.H., Campo L., Chia S.K., English R., Pastorek J., Sly W.S., Ratcliffe P., and Harris A.L. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am. J. Pathol. 158 (2001) 1011-1019
45. Yoshimura H., Dhar D.K., Kohno H., Kubota H., Fujii T., Ueda S., Kinugasa S., Tachibana M., and Nagasue N. Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin. Cancer Res. 10 (2004) 8554-8560